Glasgow life sciences pioneer behind IBS treatment gets £19m boost in one of largest investments of its kind
“Our mission is to redefine the standard of care in gastrointestinal disease” – James McIlroy, founder and CEO A Scottish life sciences pioneer behind treatments for conditions such as irritable bowel syndrome and liver cirrhosis has completed one of the …